Silva Pharmaceuticals Limited (DSE:SILVAPHL)
Bangladesh
· Delayed Price · Currency is BDT 8.90
-0.50 (-5.32%)
At close: Mar 8, 2026
Silva Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Market Capitalization | 1,242 | 1,461 | 1,952 | 2,948 | 3,290 | 2,689 | Upgrade
|
| Market Cap Growth | 0% | -25.17% | -33.80% | -10.37% | 22.34% | 7.65% | Upgrade
|
| Enterprise Value | 1,163 | 1,362 | 1,820 | 2,813 | 3,132 | 2,480 | Upgrade
|
| Last Close Price | 9.10 | 10.70 | 14.16 | 21.29 | 23.42 | 18.63 | Upgrade
|
| PE Ratio | - | - | - | 89.14 | 32.17 | 22.44 | Upgrade
|
| PS Ratio | 3.48 | 3.81 | 3.26 | 4.11 | 4.22 | 3.36 | Upgrade
|
| PB Ratio | 0.61 | 0.69 | 0.87 | 1.26 | 1.42 | 1.18 | Upgrade
|
| P/TBV Ratio | 0.61 | 0.69 | 0.87 | 1.26 | 1.42 | 1.19 | Upgrade
|
| P/FCF Ratio | 372.78 | 225.07 | - | - | - | 32.71 | Upgrade
|
| P/OCF Ratio | 149.26 | 107.73 | 570.94 | 42.06 | 20.45 | 16.87 | Upgrade
|
| EV/Sales Ratio | 3.26 | 3.55 | 3.04 | 3.92 | 4.02 | 3.10 | Upgrade
|
| EV/EBITDA Ratio | - | - | 172.70 | 26.22 | 17.96 | 11.96 | Upgrade
|
| EV/EBIT Ratio | - | - | - | 62.82 | 28.02 | 17.45 | Upgrade
|
| EV/FCF Ratio | 348.90 | 209.82 | - | - | - | 30.16 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 4.29 | 0.56 | 0.55 | 0.20 | Upgrade
|
| Debt / FCF Ratio | 9.61 | 4.87 | - | - | - | 0.52 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.03 | -0.03 | -0.05 | -0.07 | -0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.04 | 1.13 | -7.13 | -1.11 | -0.93 | -1.10 | Upgrade
|
| Net Debt / FCF Ratio | -23.88 | -10.97 | 2.54 | 7.15 | 9.67 | -2.77 | Upgrade
|
| Asset Turnover | 0.16 | 0.16 | 0.24 | 0.28 | 0.31 | 0.33 | Upgrade
|
| Inventory Turnover | 0.61 | 0.61 | 0.89 | 1.00 | 1.04 | 1.07 | Upgrade
|
| Quick Ratio | 5.10 | 5.97 | 5.17 | 5.11 | 3.76 | 6.13 | Upgrade
|
| Current Ratio | 12.55 | 14.90 | 12.67 | 11.61 | 7.70 | 12.15 | Upgrade
|
| Return on Equity (ROE) | -6.88% | -6.09% | -2.81% | 1.42% | 4.45% | 5.36% | Upgrade
|
| Return on Assets (ROA) | -3.63% | -3.24% | -1.23% | 1.11% | 2.80% | 3.62% | Upgrade
|
| Return on Invested Capital (ROIC) | -6.68% | -5.73% | -2.20% | 1.34% | 4.66% | 5.56% | Upgrade
|
| Return on Capital Employed (ROCE) | -6.20% | -5.50% | -2.10% | 1.90% | 4.60% | 6.00% | Upgrade
|
| Earnings Yield | -11.71% | -9.10% | -3.30% | 1.12% | 3.11% | 4.46% | Upgrade
|
| FCF Yield | 0.27% | 0.44% | -1.52% | -0.57% | -0.51% | 3.06% | Upgrade
|
| Dividend Yield | - | - | 0.71% | 0.47% | 1.28% | 2.68% | Upgrade
|
| Payout Ratio | - | - | - | 75.66% | 46.70% | 39.46% | Upgrade
|
| Total Shareholder Return | - | - | 0.71% | 0.47% | 1.28% | 2.68% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.